Ibex Investors LLC Dexcom Inc Transaction History

Ibex Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$28.07 - $38.18 $53,810 - $73,191	-1,917 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $11,956 - $16,554	443 Added 30.05%	1,917 $230,000
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $60,383 - $94,957	-2,586 Reduced 63.69%	1,474 $211,000
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $71,212 - $102,393	4,060 New	4,060 $386,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.